PHARMA TECH LABS – ALBUTEROL 5MG (CLEN ALTERNATIVE)

$80.00

Available

  • CHEMICAL NAME: SALBUTAMOL
  • DOSE: 5MG/CAPSULE
  • QUANTITY: 100 CAPSULES 
Minimum quantity purchase applies for this product
No special instructions

Description

Albuterol is also known as Salbutamol. It is one of the best, yet least known fat burners on the market. Almost all steroid users and fitness enthusiasts have heard about Clenbuterol. Sounds somewhat familiar to Albuterol, does it not? Because it is! Clenbuterol and Albuterol are both in the same category of drugs, known as beta-2 adrenergic agonists. In short, Albuterol and Clenbuterol burn fat through the exact same mechanism.

So now you may be wondering what is the difference between Clenbuterol and Albuterol? The main difference is the active life The active life of a compound is the amount of time it takes for that compound to leave the body from the time it ingested. Albuterol has a much shorter half-life than Clenbuterol. This means that Albuterol leaves the body much quicker, which results in much fewer side effects. So the biggest advantage that Albuterol has over Clenbuterol is that a user will be able to take full advantage of the beta-2 adrenergic agonists’ fat-burning properties while limiting the side effects. This makes Albuterol a highly desired compound, by those that just do not seem to be able to tolerate the side effects of Clenbuterol easily.  Additionally, Albuterol is not liver toxic, much like many Oral steroids, however, neither is Clenbuterol.

The recommended dosage for Albuterol ranges from 10-20mg per day, divided into 2-3 poses per day. For example, a user taking 10mg per day, should take 5mg in the morning and 5mg in the evening. A user taking 20mg per day, can take 10mg in the morning, 5mg in the afternoon, and 5mg in the evening. It should be advised that no more than 5mg should be ingested in a single dose for individuals that. are just starting out. Albuterol can easily be stacked with Injectable Steroids, Oral Steroids, or Sarms without any issues.